Approval · Notice of Compliance 13938 · 2012
SILENOR: Notice of Compliance 13938
Issued December 13, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13938
- Date
- December 13, 2012
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Hypnotic
Products in this notice
Medicinal ingredients
- DOXEPIN HCL 3 MG per TAB
- DOXEPIN HCL 6 MG per TAB